Zobrazeno 1 - 10
of 41
pro vyhledávání: '"D P, Kontoyiannis"'
Autor:
D P Kontoyiannis
Publikováno v:
Bone Marrow Transplantation. 46:165-173
Antifungal prophylaxis in hematopoietic stem cell transplant recipients is a rapidly evolving field. For this prophylaxis to be beneficial and cost-effective, the risk of a life-threatening invasive fungal infection (IFI) should outweigh the risks of
Autor:
Hend Hanna, R Y Hachem, Yunfang Jiang, I. Raad, D P Kontoyiannis, Maha Boktour, Claude Afif, Harrys A. Torres
Publikováno v:
Leukemia. 22:496-503
In patients with hematologic malignancy, invasive aspergillosis continues to be associated with high mortality even when treated with conventional antifungal therapy. To investigate novel antifungal agents, we compared 53 patients who received posaco
Autor:
G. Samonis, S. Maraki, N. Anatoliotakis, M. Anatoliotaki, H. Apostolakou, A. N. Margioris, Y. Tselentis, D. P. Kontoyiannis
Publikováno v:
Medical Mycology. 40:139-142
Autor:
R, Ben-Ami, G, Rahav, H, Elinav, I, Kassis, I, Shalit, T, Gottesman, O, Megged, M, Weinberger, P, Ciobotaro, P, Shitrit, G, Weber, A, Paz, D, Miron, I, Oren, J, Bishara, C, Block, N, Keller, D P, Kontoyiannis, M, Giladi, Soboh, Soboh
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 19(8)
The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiar
Autor:
J. M. W. Quinn, M. C. Lecomte, S. L. Asplund, K. Sugita, T. J. Huang, T. Matsushita, C. Rahuel, M. Nees, A. Takagi, J. E Compston, H. Okada, M. T. Canciani, S. Bord, M. A. Scott, J. P. Cartron, C. Capoferri, R. E. Lewis, Y. Colin, S. Breit, T. Kojima, W. El Nemer, D. P. Kontoyiannis, A. Yoshioka, J. Takamatsu, E. Frith, E. Gauthier, E. Lee, M. E. Reid, M. Muckenthaler, M. Cole-Sinclair, J. W. Sentry, P. Gane, Y. Kroviarski, A. E. Kulozik, K. Yamamoto, G. Burgess, J. I. O. Craig, M. Pfoersich, M. T. Gillespie, T. Yamazaki, T. Murate, S. H. Kroft, M. Sugimoto, T. Adachi, C. Hagemeier, U. Schaefer, W.-J. Cheng, C. Le Van Kim, F. P. L. Lai, G. R. Halverson, D. C. Ireland, N. J. Karandikar, H.-G. Schneider, P. M. Mannucci, H. Saito, R. W. McKenna
Publikováno v:
British Journal of Haematology. 126
Autor:
D P, Kontoyiannis, P J, Murray
Publikováno v:
Mycoses. 46(5-6)
Fluconazole toxicity was previously shown to require intact mitochondria in Saccharomyces cerevisiae, however, the mechanism of mitochondrial-dependent azole toxicity is unclear. Here we show that fluconazole toxicity is not attenuated by the overexp
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 4(1)
Blood and marrow transplantation (BMT) is increasingly used to treat malignant and nonmalignant diseases. Despite significant advances in the management of transplant recipients, however, fungal infections remain important life-threatening complicati
Autor:
D P, Kontoyiannis
Publikováno v:
Pharmacotherapy. 21(8 Pt 2)
Invasive fungal infections, especially candidiasis and aspergillosis, are a major cause of morbidity and mortality. Many controversies surround the management of these infections. A critical overview of the recent Infectious Diseases Society of Ameri
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 3(1)
Autor:
G, Samonis, S, Maraki, I, Hajiioannou, I, Chatzinikolaou, K V, Rolston, G P, Bodey, D P, Kontoyiannis
Publikováno v:
Journal of chemotherapy (Florence, Italy). 13(1)
Crl:CD1 (ICR) BR mice were colonized in the gastrointestinal (GI) tract with Candida albicans. This strain was susceptible to ketoconazole (MIC=0.25 microg/ml), itraconazole (minimum inhibitory concentration, MIC=0.25 microg/ml), and fluconazole (MIC